
Satoru Todo
Sapporo, 0608638, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 48 publications
The Importance of Bringing Transplantation Tolerance to the Clinic.
Journal: Transplantation
Published: April 26, 2021
Anti-Donor Regulatory T-Cell Therapy in Adult-to-Adult Living Donor Liver Transplantation: A Case Report.
Journal: Transplantation proceedings
Published: March 19, 2021
Triazolopyrimidine derivative NK026680 and donor-specific transfusion induces CD4+CD25+Foxp3+ T cells and ameliorates allograft rejection in an antigen-specific manner.
Journal: Transplant immunology
Published: January 20, 2020
Expanded living-donor liver transplantation criteria for patients with hepatocellular carcinoma based on the Japanese nationwide survey: the 5-5-500 rule - a retrospective study.
Journal: Transplant international : official journal of the European Society for Organ Transplantation
Published: October 24, 2018
Mesothelin-Specific Immune Responses and Targeted Immunotherapy for Mesothelin-Expressing Tumors.
Journal: EBioMedicine
Published: September 24, 2017
Anti-donor regulatory T cell therapy in liver transplantation.
Journal: Human immunology
Published: September 08, 2017
Clinical impacts of mesothelin expression in gastrointestinal carcinomas.
Journal: World journal of gastrointestinal pathophysiology
Published: September 29, 2015
Olfactory Receptor Family 7 Subfamily C Member 1 Is a Novel Marker of Colon Cancer-Initiating Cells and Is a Potent Target of Immunotherapy.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 30, 2015
A pilot study of operational tolerance with a regulatory T-cell-based cell therapy in living donor liver transplantation.
Journal: Hepatology (Baltimore, Md.)
Published: July 01, 2015
Resection of liver metastasis derived from alpha-fetoprotein-producing gastric cancer-report of 4 cases.
Journal: International cancer conference journal
Published: May 28, 2015
Novel anti-inflammatory agent 3-[(dodecylthiocarbonyl)-methyl]-glutarimide ameliorates murine models of inflammatory bowel disease.
Journal: Inflammation research : official journal of the European Histamine Research Society ... [et al.]
Published: April 27, 2015
Last Updated: 09/26/2026